RecruitingNCT04340024

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients


Sponsor

National Cancer Centre, Singapore

Enrollment

5,000 participants

Start Date

Sep 30, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

Patients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the study. Blood and/or matched tumour-normal tissue pairs will be collected. Blood and/or tissue samples will be processed and studied for genetic and biochemical markers that have potential to be used for predicting sensitivity to radiation.


Eligibility

Min Age: 21 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting biological samples and health information from cancer patients who had severe side effects from radiation therapy or who have a cancer type associated with increased sensitivity to radiation. Researchers hope to discover biological markers — signals in blood or tissue — that predict in advance how a person will react to radiation treatment. **You may be eligible if...** - You are between 21 and 98 years old - You are a cancer patient who experienced significant side effects from radiotherapy - OR you have a type of cancer that is known to be associated with heightened sensitivity to radiation **You may NOT be eligible if...** - You are under 21 or 99 years of age or older Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Cancer Center Singapore

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04340024


Related Trials